(Q43828519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marta Maschio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Francesca Sperati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andrea Pace

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Loredana Dinapoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Alessandra Fabi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Paola Muti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

1 reference

25 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

205-214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107994%20AND%20SRC:MED&resulttype=core&format=json

Epileptic seizures during follow-up of patients treated for primary brain tumors.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Pregabalin in patients with primary brain tumors and seizures: a preliminary observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Outcome and tolerability of topiramate in brain tumor associated epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Levetiracetam therapy in patients with brain tumour and epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Tiagabine in glial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Medical management of patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Optimizing therapy of seizures in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Management of epileptic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Epilepsy in low‐grade gliomas: The impact on cognitive function and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Interactions between antiepileptic and chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

The importance of drug interactions in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Antiepileptic drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Anticonvulsant usage is associated with an increased risk of procarbazine hypersensitivity reactions in patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Drug interactions between chemotherapeutic regimens and antiepileptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

The course of neurocognitive functioning in high-grade glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Epilepsy in cerebral glioma: timing of appearance and histological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0460-X

Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use

21 January 2018

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study

1 reference

12 December 2020

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

1 reference

12 December 2020

FUNCTIONAL EVALUATION: THE BARTHEL INDEX

1 reference

12 December 2020

Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient

1 reference

12 December 2020

Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors

1 reference

12 December 2020

Cognitive functioning and quality of life in malignant glioma patients: a review of the literature

1 reference

12 December 2020

Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression

1 reference

12 December 2020

Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia

1 reference

12 December 2020

Gabapentin to control seizures in children undergoing cancer treatment

1 reference

12 December 2020